Background: Mitral annular calcification (MAC) is common, particularly in the elderly. While thought to occasionally produce significant mitral regurgitation, it is considered a rare cause of mitral stenosis.
Methods: Echocardiogram reports from general cardiology outpatients were searched for phrases regarding severe MAC and, separately, for mitral stenosis. Rheumatic disease or other mitral valve (MV) pathology was excluded. Mean MV and aortic valve (AV) gradients were recorded. The presence or absence of anterior MAC was noted and a semi-quantitative assessment of anterior mitral leaflet (AML) mobility was made. Ten patients with annuloplasty rings served for comparison.
Results: Group A (22 patients with moderately/severely reduced AML mobility) had a mean MV gradient of 7 mm Hg (range 3-14) vs. 3 mm Hg (range 1-5) in group B (21 patients with normal/mildly reduced AML mobility), p<0.0001. Annuloplasty patients had a mean MV gradient of 3 mm Hg, p<0.001 vs. group A but similar to group B. Mean AV gradient was 27 mm Hg (range 4-48) in group A vs. 14 mm Hg in group B (range 3-40), p=0.013. No patient had more than mild mitral regurgitation.
Conclusion: MAC producing a potentially important MV gradient is not rare in the general cardiology population. Reduced AML mobility appears to be necessary for a gradient >5 mm Hg. Significant AV gradients are commonly associated, reflecting greater overall cardiac calcification. These patients can be easily identified by looking for reduced AML mobility as part of widespread cardiac calcification.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijcard.2006.11.142 | DOI Listing |
Eur J Pharmacol
January 2025
Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China. Electronic address:
Thymocyte selection-associated high mobility group box protein (TOX) is regarded as a crucial transcription factor involved in T cell exhaustion in acute myeloid leukemia (AML). Previous studies have identified aberrant TOX expression as a major oncogenic driver in hematologic malignancies, indicating that TOX may potentially be both an immune biomarker and an immunotherapy target. However, due to heterogeneity in the distribution patterns of TOX and its correlation with clinical prognosis, the mechanism underlying TOX-mediated tumor immune responses remains unclear.
View Article and Find Full Text PDFInt J Cardiovasc Imaging
November 2024
Department of Cardiology, Istanbul University Cerrahpasa Institute of Cardiology, Istanbul, Turkey.
This study aimed to identify the phenotypic features contributing to the development of left ventricular outflow tract obstruction (LVOTO) in patients with hypertrophic cardiomyopathy (HCM) and to evaluate the genotype‒phenotype relationship. This cross-sectional study included 96 patients diagnosed with HCM (mean age: 56.9 ± 13.
View Article and Find Full Text PDFSensors (Basel)
September 2024
Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Advancements in wireless communication and automation have revolutionized mobility systems, notably through autonomous vehicles and unmanned aerial vehicles (UAVs). UAV spatial coordinates, determined via Global Positioning System (GPS) signals, are susceptible to cyberattacks due to unencrypted and unauthenticated transmissions with GPS spoofing being a significant threat. To mitigate these vulnerabilities, intrusion detection systems (IDSs) for UAVs have been developed and enhanced using machine learning (ML) algorithms.
View Article and Find Full Text PDFIran J Immunol
December 2023
Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Background: Thymocyte selection-associated high mobility group box protein (TOX) and members of the nuclear receptor 4A (NR4A) are known as transcription factors involved in T cell exhaustion.
Objective: To evaluate the mRNA expression of TOX and NR4A1-3 in CD8+ T cells in acute leukemia.
Methods: Blood samples were obtained from 21 ALL and 6 AML patients as well as 20 control subjects.
Fukushima J Med Sci
January 2024
Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University.
Acute myeloid leukemia (AML) arises from preleukemic conditions. We have investigated the pathogenesis of typical preleukemia, myeloproliferative neoplasms, and clonal hematopoiesis. Hematopoietic stem cells in both preleukemic conditions harbor recurrent driver mutations; additional mutation provokes further malignant transformation, leading to AML onset.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!